In the MediaHome› Company Overview› News & Events› In the MediaJuly 21, 2021 The first Digital Tomosynthesis Mastographer with 2D & 3D Artificial Intelligence Software in G.N. Read MoreJune 18, 2021 Latest iCAD 3D mammography AI gains CE mark Read MoreJune 15, 2021 Latest Version of iCAD’s Breast Imaging Software Gets CE Mark Read MoreJune 14, 2021 Mammographic Microcalcifications and Risk of Breast Cancer Read MoreJune 11, 2021 iCAD and Sectra partner on distribution for ProFound AI Read MoreJune 8, 2021 iCAD (ICAD) Receives a Buy from Oppenheimer Read MoreMay 7, 2021 The effect on interval cancer rates of the use of an AI-based algorithm in mammography Read MoreApril 27, 2021 Une nouvelle arme pour détecter le cancer du sein à Amiens Read MoreApril 26, 2021 New research confirms iCAD’s ProFound AI aids breast cancer detection with digital breast tomosynthesis Read MoreApril 26, 2021 New Research Supports Clinical Value of ProFound AI in DBT Read MoreApril 26, 2021 Montclair Hospital Gets New Tools In Fight Against Breast Cancer Read MoreApril 23, 2021 FOX19 For a Cure: ProFound AI Assists TriHealth in the Fight Against Breast Cancer Read More Previous 1 … 7 8 9 10 11 … 22 Next